Dear Patients and Visitors

With nearly 22 years of fruitful clinical experience, I am convinced that the initial positive impressions formed during the first communication between a doctor and a patient can impact the subsequent development of medical processes as significantly as high-quality medications, modern equipment, a safe environment, and the expertise of the medical staff. Personal satisfaction is an essential component of achieving the best treatment outcomes, particularly in oncology and oncoplastic breast surgery.
Empathy, trust, and respect between the doctor and patient largely depend on the doctor’s communication skills, though other, less subjective factors can also play a role.
In traditional, multi-specialty medical institutions, common issues include appointment scheduling errors, inefficient service timing, prolonged waiting for various medical procedures, unnecessary bureaucracy, and more. These seemingly minor obstacles can further aggravate patients already in a stressful state, causing feelings of vulnerability and disappointment.
Anyone who has experienced this “pleasure” as a patient or their relative will understand exactly what I mean.
The idea behind our consulting center is to create maximum comfort in delivering high-quality medical care, and I believe we have been very successful in this regard.
Without exaggeration, I can confidently say that the Irakli Kokhreidze Consulting Center is precisely the place where the patient is always the central focus! Simultaneously, patients receive premium-quality medical services from experts in various fields.
After nearly two years of operation, our center has truly established itself as a patient-centered medical institution. It is no surprise that, amid growing competition, we are distinguished and trusted, and based on the feedback from over 1,800 consulted patients, I can say that we are also loved.
We look forward to welcoming you to the Irakli Kokhreidze Consulting Center and wish you good health!
Professor Irakli Kokhreidze MD., PhD, 2022.